Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulipristal versus standard surgical treatment for symptomatic uterine fibroids
NL-OMON52721Phase 4Recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Dec 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ulipristal in Fibromyoma (LM) (2 arms), sponsored by Vrije University Medical Center. Primary endpoints: Fibroid-specific quality of life symptom severity score, Direct health care costs and 2 more. Started Dec 2018; status: recruiting.
02
Drugs
ulipristal
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on NL-OMON52721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52721.